Invention Application
- Patent Title: NOVEL CARBONATE COMPOUND HAVING PYRROLOPYRIMIDINE SKELETON OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
-
Application No.: US17619379Application Date: 2020-06-17
-
Publication No.: US20220233566A1Publication Date: 2022-07-28
- Inventor: Hitoshi MIYAKOSHI , Nozomu TANAKA , Yu KOBAYAKAWA
- Applicant: TAIHO PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: TAIHO PHARMACEUTICAL CO., LTD.
- Current Assignee: TAIHO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Tokyo
- Priority: JP2019-113172 20190618,JP2019-157375 20190829
- International Application: PCT/JP2020/023661 WO 20200617
- Main IPC: A61K31/7064
- IPC: A61K31/7064 ; C07H19/14 ; A61P35/00 ; A61K31/495 ; A61N5/10

Abstract:
There is provided a novel carbonate compound of a nucleoside having a pyrrolopyrimidine skeleton having an excellent antitumor effect, or a pharmaceutically acceptable salt thereof and a method for preventing and/or treating a tumor in combination with an alkylating agent and/or a radiation therapy. According to one aspect of the present invention, there is provided a compound represented by the following general formula (1): or a pharmaceutically acceptable salt thereof, and a method for preventing and/or treating a tumor in combination with an alkylating agent and/or a radiation therapy.
Information query
IPC分类: